Furuhashi M - Search Results

1

Impact of use of angiotensin II receptor blocker on all-cause mortality in hemodialysis patients: prospective cohort study using a propensity-score analysis.

Tanaka M, Yamashita T, Koyama M, Moniwa N, Ohno K, Mitsumata K, Itoh T, Furuhashi M, Ohnishi H, Yoshida H, Tsuchihashi K, Miura T; BOREAS HD study Investigators. Tanaka M, et al. Among authors: furuhashi m. Clin Exp Nephrol. 2016 Jun;20(3):469-78. doi: 10.1007/s10157-015-1182-3. Epub 2015 Oct 24. Clin Exp Nephrol. 2016. PMID: 26500097

2

Prevalence of asymptomatic ST segment elevation in right precordial leads with right bundle branch block (Brugada-type ST shift) among the general Japanese population.

Furuhashi M, Uno K, Tsuchihashi K, Nagahara D, Hyakukoku M, Ohtomo T, Satoh S, Nishimiya T, Shimamoto K. Furuhashi M, et al. Heart. 2001 Aug;86(2):161-6. doi: 10.1136/heart.86.2.161. Heart. 2001. PMID: 11454832 Free PMC article.

3

Sonoclot coagulation analysis: new bedside monitoring for determination of the appropriate heparin dose during haemodialysis.

Furuhashi M, Ura N, Hasegawa K, Yoshida H, Tsuchihashi K, Miura T, Shimamoto K. Furuhashi M, et al. Nephrol Dial Transplant. 2002 Aug;17(8):1457-62. doi: 10.1093/ndt/17.8.1457. Nephrol Dial Transplant. 2002. PMID: 12147794

4

Myocardial iodine-123-metaiodobenzylguanidine (123I-MIBG) imaging in Brugada syndrome.

Furuhashi M, Uno K, Tsuchihashi K. Furuhashi M, et al. Circulation. 2002 Sep 24;106(13):e59-60; author reply e59-60. doi: 10.1161/01.cir.0000031719.90222.e8. Circulation. 2002. PMID: 12270878 No abstract available.

5

Serum ratio of heart-type fatty acid-binding protein to myoglobin. A novel marker of cardiac damage and volume overload in hemodialysis patients.

Furuhashi M, Ura N, Hasegawa K, Yoshida H, Tsuchihashi K, Nakata T, Shimamoto K. Furuhashi M, et al. Nephron Clin Pract. 2003;93(2):C69-74. doi: 10.1159/000068520. Nephron Clin Pract. 2003. PMID: 12616033 Clinical Trial.

6

Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension.

Furuhashi M, Ura N, Higashiura K, Murakami H, Tanaka M, Moniwa N, Yoshida D, Shimamoto K. Furuhashi M, et al. Hypertension. 2003 Jul;42(1):76-81. doi: 10.1161/01.HYP.0000078490.59735.6E. Epub 2003 Jun 9. Hypertension. 2003. PMID: 12796280

7

Right bundle branch block and coved-type ST-segment elevation mimicked by acute cholecystitis.

Furuhashi M, Uno K, Satoh S, Hoshikawa K, Sakai E, Tsuchihashi K, Shimamoto K. Furuhashi M, et al. Circ J. 2003 Sep;67(9):802-4. doi: 10.1253/circj.67.802. Circ J. 2003. PMID: 12939560 Free article.

8

Role of adiponectin in insulin-resistant hypertension and atherosclerosis.

Murakami H, Ura N, Furuhashi M, Higashiura K, Miura T, Shimamoto K. Murakami H, et al. Among authors: furuhashi m. Hypertens Res. 2003 Sep;26(9):705-10. doi: 10.1291/hypres.26.705. Hypertens Res. 2003. PMID: 14620925 Free article.

9

Utility of serum ratio of heart-type fatty acid-binding protein to myoglobin for cardiac damage regardless of renal dysfunction.

Furuhashi M, Ura N, Hasegawa K, Tsuchihashi K, Nakata T, Shimamoto K. Furuhashi M, et al. Circ J. 2004 Jul;68(7):656-9. doi: 10.1253/circj.68.656. Circ J. 2004. PMID: 15226631 Free article.

10

Possible impairment of transcardiac utilization of adiponectin in patients with type 2 diabetes.

Furuhashi M, Ura N, Moniwa N, Shinshi Y, Kouzu H, Nishihara M, Kokubu N, Takahashi T, Sakamoto K, Hayashi M, Satoh N, Nishitani T, Shikano Y, Shimamoto K. Furuhashi M, et al. Diabetes Care. 2004 Sep;27(9):2217-21. doi: 10.2337/diacare.27.9.2217. Diabetes Care. 2004. PMID: 15333487

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

377 results

Search Page

Filters